Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) is a clinical-stage biotechnology firm focused on developing drugs for Alzheimer’s disease. The company’s Simufilam drug is in Phase 3 of clinicals trials. At this sta...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Cassava Sciences is trading near its 52 week lows. Cassava Sciences has enrolled over 60 patients in its phase three trials. I believe Cassava Sciences has the best risk to reward ratio in the stock market. For further details see: 3 Key Points To Remember About Cassava ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SoFi Technologies (NASDAQ: SOFI ) stock is slipping on Tuesday and may see further falls this week ahead of student loan news. Source: Michael Vi / Shutterstock The current federal student loan moratorium is se...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) stock is falling on Tuesday as investors react to a recent fireside chat from CEO Remi Barbier. Source: Postmodern Studio / Shutterstock.com Cassava Sciences has been hit or mi...
Twitter (TWTR) remained a hot topic in Tuesday's intraday action, rising again on further revelations about a major investment from Elon Musk. In the latest development, Musk will join the company's board of directors. Elsewhere in the market, analyst comments are weighing on shares of Qualco...
Alzheimer’s drug developer, Cassava Sciences (SAVA -9.1%), has snapped two days of back-to-back gains on Tuesday after an event attended by the company’s Chief Executive Officer Remi Barbier. The presentation and fireside chat was scheduled to start at 9 am EST on Tuesday, the c...
Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...
– All Stakeholder Are Welcome to Listen by Webcast – – Event To Be Held Tuesday, April 5 th , 9am ET – AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focu...
The following slide deck was published by Cassava Sciences, Inc. in conjunction with this event. For further details see: Cassava Sciences (SAVA) Investor Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...